Lipotoxicity is the most common cause of severe
kidney disease, with few treatment options available today. Precision toxicology can improve detection of subtle intracellular changes in response to exogenous substrates; thus, it facilitates in-depth research on bioactive molecules that may interfere with the onset of certain diseases. In the current study,
troxerutin significantly relieved nephrotoxicity, increased endurance, and improved systemic energy metabolism and renal
inflammation in OTA-induced nephrotic mice. Lipidomics showed that
troxerutin effectively reduced the levels of
triglycerides,
phosphatidylcholines, and
phosphatidylethanolamines in nephropathy. The mechanism was partly attributable to
troxerutin in alleviating the aberrantly up-regulated expression of
sphingomyelinase, the
cystic fibrosis transmembrane conductance regulator, and
chloride channel 2. Renal tubular epithelial cells, the main site of toxin-induced accumulation of
lipids in the kidney, were subjected to transcriptomic profiling, which uncovered several metabolic factors relevant to aberrant
lipid and
lipoprotein metabolism. Our work provides new insights into the molecular features of toxin-induced lipotoxicity in renal tubular epithelial cells in vivo and demonstrates the function of
troxerutin in alleviating OTA-induced
nephrosis and associated systemic energy metabolism disorders.-Yang, X., Xu, W., Huang, K., Zhang, B., Wang, H., Zhang, X., Gong, L., Luo, Y., He, X. Precision toxicology shows that
troxerutin alleviates
ochratoxin A-induced renal lipotoxicity.